Financials
- Financial year
- 2025
- Total assets
- €258,120
- Profit
- €16,296
- Solvency
- 9.6%
Total assets▲ 4.1%
Net result
20182025
Alchemich Farma
ActiveSummary
Alchemich Farma has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €24,793 and a net result of €16,296. Equity is shrinking by about 27% per year across the filed financial years. Its solvency ranks better than 35% of 74 sector peers (NACE 21, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Overview
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE 21201
1 site
Size
€258,120total assets 2025
- Equity
- €24,793
- Profit
- €16,296
Turnover not published (abbreviated or micro format)
Structure
- GERITS Jaak Maria FransDirector
- SMIRNOVA Svetlana VasiljevnaDirector
2025 accounts 169 days early2 of 5 deeds summarised
Why 88raises risk1 change of registered office in 24 monthsEquity €24,793 (9.6% of total assets)lowers riskLiquidity: current ratio 24.25, cash €86,241Figures for financial year 2025 (filed 13-02-2026)Show the evidence
Checked score
Score 2025
88
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 70% of its sector peers (NACE 21, micro)
Financial strength · tick = 2024
Strong
Solvency
35+7
equity 9.6% of total assets
Liquidity
92-8
short-term debt 3.3% · cash 33.4%
Profitability
76+67
return on assets 6.3%
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.3%
12-2024: 0.3%● unchanged vs 11-2024
01-2025: 0.3%● unchanged vs 12-2024
02-2025: 0.3%● unchanged vs 01-2025
03-2025: 0.3%● unchanged vs 02-2025
04-2025: 0.3%● unchanged vs 03-2025highest value
05-2025: 0.3%● unchanged vs 04-2025
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.2%▼ -0.1 percentage points vs 06-2025
08-2025: 0.2%● unchanged vs 07-2025
09-2025: 0.2%● unchanged vs 08-2025
10-2025: 0.2%● unchanged vs 09-2025
11-2025: 0.2%● unchanged vs 10-2025
12-2025: 0.2%● unchanged vs 11-2025
01-2026: 0.2%● unchanged vs 12-2025
02-2026: 0.2%● unchanged vs 01-2026
03-2026: 0.1%▼ -0.1 percentage points vs 02-2026lowest value
04-2026: 0.3%▲ +0.2 percentage points vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.3%● unchanged vs 05-2026
07-2026: 0.3%● unchanged vs 06-2026
08-2026: 0.3%● unchanged vs 07-2026
09-2026: 0.3%● unchanged vs 08-2026
10-2026: 0.3%● unchanged vs 09-2026
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity ample (current ratio 24.25, compared with 16.54 in 2024, above the usual 1.5; short-term debt: 3.3% and cash: 33.4% of total assets), but 90.4% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 21, micro): better than 33% on solvency, 85% on liquidity, 67% on profitability and 96% on growth.
The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-02-2026, 169 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
169 days early
2024
57 days early
2023
58 days early
2022
62 days early
2021
51 days early
2020
44 days early
2019
32 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 68 days before the deadline; the sector median (NACE 21) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 4 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
- Appointments: GERITS Jaak Maria Frans (statutory…Capital increase · Declaration ·…
- Annual accounts filedfinancial year 2025 · micro…
- Back to profitnet €16,296
Key points
By topic
Board & ownership
- Board
- 2 members
- GERITS Jaak Maria FransDirector
- SMIRNOVA Svetlana VasiljevnaDirector
Timeline
- Events
- 26
- Since
- 2010
- Next accounts
- by 31-07-2027
- 04-06-2025Annual accounts filed
- 31-12-2024Weakest financial year
- 31-12-2024Liquidity doubles
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Manufacture of basic pharmaceutical products and pharmaceutical preparationsNACE 21201
- Founded
- 28-04-2008
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 16
- Who signs
- All directors jointly
- Annual meeting
- Last Friday of May at 17:00
- Purpose
- “De productie en verkoop van farmaceutische producten,voedingssupplementen en aanverwante…” (deed in Dutch)
Key facts about Alchemich Farma
- What is the company number of Alchemich Farma?
- 0897.592.963. In Belgium the VAT number is the company number with BE in front: BE 0897.592.963.
- Where is Alchemich Farma based?
- The registered office is at Stationsstraat 45, 3530 Houthalen-Helchteren.Company details
- What does Alchemich Farma do?
- According to the KBO register, the main activity is manufacture of basic pharmaceutical products and pharmaceutical preparations (NACE 21201).
- What is the legal form of Alchemich Farma?
- Private limited company (BV).
- When was Alchemich Farma founded?
- On 28-04-2008.
- Is Alchemich Farma still active?
- Yes, Alchemich Farma is an active enterprise in the KBO register.
- What is the turnover of Alchemich Farma?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is Alchemich Farma profitable?
- In financial year 2025, Alchemich Farma made a profit of €16,296.
- Where can I find the annual accounts of Alchemich Farma?
- Alchemich Farma filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Alchemich Farma due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to Alchemich Farma
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.